Article
Genetic validation of aldolase and glyceraldehyde-3-phosphate dehydrogenase as drug targets in Trypanosoma brucei.
Molecular and biochemical parasitology - 1 Jan 2010
Cáceres Ana Judith, Michels Paul A M, Hannaert Véronique
Abstract excerpt
Aldolase (ALD) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) of Trypanosoma brucei are considered to be promising targets for chemotherapeutic treatment of African sleeping sickness, because glycolysis is the single source of ATP for the parasite when living in the human bloodstream. Moreover, these enzymes appeared to possess distinct kinetic and structural properties that have already been exploited for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
